Vaginal Rejuvenation with Radio Frequency Energy

Aug 19, 2022

No incision will be made. The treatment is non-invasive, meaning that radio frequency (RF) generates heat by sending energy into the tissue. This procedure targets specific tissue areas responsible for vulvo-vaginal laxity and other symptoms.

The patient will be paced on the gynecological treatment table in a dorsal litothony position. A return pad will be placed on the buttocks and attached to the RF generator. The treatment will include the entire vagina from the apex in a circular way along the vaginal top, sidewalls and bottom and covered from five separate delivery positions. This includes the entire vagina, the anterior area including the bladder and urethra, sides with labia majora and minora from the mons pubis back to the perineal area to the rectal edge. The mons pubis, bladder area, the labia and perineal area will take 10-15 minutes, the vaginal area 5-10 minutes. The patient can leave immediately after the treatment is terminated.

Three consequential treatments 4 weeks apart increases the beneficiary effect of the treatment and we recommend repeat treatments at 4 and 8 weeks after the initial treatment. A positive effect of the treatment is noticeable already 3-4 weeks after the start of treatment. Another treatment is suggested 8-12 months later for prolonged benefit of the treatment.

Before treatment is started each patient is asked to fill out questionnaires about her symptoms to follow and evaluate the progress of the treatment. She will fill out the same questionnaire before each treatment.  The questionnaires to fill out are:

VHIS (Vaginal Health Index Score)

VAS (Visual Analogue Scale)

FSFI (Female Sexual Function Index)

PFDI -20 (Pelvic Floor Disability Index)

VLQ (Vaginal Laxity Questionnaire)

Certain criteria have been set up before vaginal rejuvenation procedure are performed:

  1. Age over 18 years
  2. Complete urine pregnancy test with negative results if premenstrual
  3. Patients complaining about significant vaginal symptoms.
  4. Normal Pap smear within 36 months prior to treatment.
  5. Patient willing to take medication 3 days prior to the treatment to prevent flare ups of possible Herpes virus infects.
  6. Uterine prolapse up to the introitus
  7. Patient is encouraged to continue current contraception practices.

A few contraindications to treatment also exist:

  1. Prolapse of uterus beyond the introitus.
  2. Active infections.
  3. Previous reconstruction with vaginal surgery or reconstructive attempts.
  4. Actively taking anti-inflammatory or immune-modulating drugs.
  5. Carriers of pacemaker or other AICD (automatic internal cardio-defibrillator)